The effects of conjugated estrogen, raloxifene and soy extract on collagen in rat bones.
OBJECTIVE
To evaluate the action of conjugated equine estrogen, raloxifene and isolated or combined genistein-rich soy extracts on collagen fibers in the bones of oophorectomized rats.


METHODS
Seventy female rats received testosterone propionate (0.1 µg/g) on the 9th day after birth. At 6 months of age, the rats were administered the vehicle (propylene glycol, 0.5 ml/day), and ten of the rats were randomly chosen to comprise the non-oophorectomized control group (GI). The other 60 rats were ovariectomized and randomized into six groups of ten as follows: GII, vehicle; GIII, conjugated equine estrogen (CEE), 50 µg/kg/day; GIV, raloxifene (RAL), 0.75 mg/kg/day; GV, genistein-rich soy extract (GSE), 300 mg/kg/day; GVI, CEE + GSE, 50 µg/kg/day + 300 mg/kg/day; and GVII, CEE + RAL, 50 µg/kg/day + 0.75 mg/kg/day. Three months after surgery, the drugs were administered for 60 consecutive days. All rats were euthanized, and their left tibiae were removed for histological routine. The histological sections were stained with hematoxylin-eosin, and picrosirius for evaluating bone microarchitecture. Types I and II collagen fibers were analyzed by immunofluorescence. Data analysis was carried out with ANOVA and Tukey's test.


RESULTS
Collagen reduction was significant in the GIII animals when compared to the other groups (p < 0.05). There was no significant difference in the thickness of collagen fibers among the groups. There was a greater quantity of type III collagen in GVI than in the other groups.


CONCLUSIONS
Our data indicate that conjugated equine estrogen improves bone quality because it increases the quantity of type I collagen while reducing the quantity of thin collagen fibers. In addition, the combination of CEE and raloxifene or genistein-rich soy extract is not as efficient as CEE itself to improve bone quality.
LIM 58, Gynecology Department, Universidade de São Paulo, São Paulo, Brazil.
F L F
FL
Condi
J M
JM
Soares
W R
WR
Teodoro
A P
AP
Veloso
E R
ER
Parra
M
M
de Jesus Simoes
E C
EC
Baracat
D000818:Animals; D001842:Bone and Bones / Q000033:anatomy & histology / Q000737:chemistry* / Q000187:drug effects; D003094:Collagen / Q000032:analysis*; D024061:Collagen Type III / Q000032:analysis; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005455:Fluorescent Antibody Technique; D010052:Ovariectomy; D010936:Plant Extracts / Q000008:administration & dosage / Q000494:pharmacology*; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013025:Glycine max / Q000737:chemistry*
D024061:Collagen Type III; D004966:Estrogens, Conjugated (USP); D010936:Plant Extracts; D020849:Raloxifene Hydrochloride; D003094:Collagen